High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer

Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer

(2010) Åsa Ehlén et al.   Journal of Translational Medicine

Towards a knowledge-based Human Protein Atlas

(2010) Mathias Uhlen et al.   NATURE BIOTECHNOLOGY

Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer

(2009) Annika Jögi et al.   MODERN PATHOLOGY

Characterization of PrEST-based antibodies towards human Cytokeratin-17

(2008) K. Larsson et al.   JOURNAL OF IMMUNOLOGICAL METHODS

The Human Protein Atlas-a tool for pathology

(2008) F Pontén et al.   JOURNAL OF PATHOLOGY

Epitope mapping of antibodies using bacterial surface display

(2008) Johan Rockberg et al.   NATURE METHODS

Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe

(2008) S M Sureban et al.   ONCOGENE

A whole-genome bioinformatics approach to selection of antigens for systematic antibody generation

(2008) Lisa Berglund et al.   PROTEOMICS